Natera (NTRA)
Natera on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as services-medical laboratories.
6.4M
Short interest
settlement 2026-09-30
3.2
Days to cover
-1.5 days vs prior
48.5%
Short share of volume
2026-10-09
2
Fails to deliver
settlement 2026-09-08
Thu 5 Nov
Next earnings
estimated date
-$84.8M
Insider flow, 90 days
0 buys, 121 sells
As of 2026-10-09.
Short interest
FINRA, twice a month. The newest 24 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in NTRA is 6,355,450 shares, up 841,272 shares over the last month. Over the last 48 readings it ranged from 2,490,476 shares (14 February 2025) to 6,355,450 shares (30 September 2026). The latest reading sits at the top of that range. At the reported average volume of 2.0M shares a day that is 3.2 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/ntra" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 6,355,450 | +32.5% | 1,983,053 | 3.20 |
| 2026-09-15 | 4,797,175 | -13.0% | 1,021,382 | 4.70 |
| 2026-08-31 | 5,514,178 | +28.4% | 1,261,367 | 4.37 |
| 2026-08-14 | 4,295,245 | -1.6% | 1,642,755 | 2.61 |
| 2026-07-31 | 4,365,205 | -12.1% | 931,729 | 4.69 |
| 2026-07-15 | 4,964,646 | -14.7% | 1,374,402 | 3.61 |
| 2026-06-30 | 5,820,616 | +34.9% | 2,115,794 | 2.75 |
| 2026-06-15 | 4,315,003 | +19.4% | 1,078,928 | 4.00 |
| 2026-05-29 | 3,614,976 | -4.5% | 1,623,949 | 2.23 |
| 2026-05-15 | 3,784,076 | -6.0% | 1,887,138 | 2.01 |
| 2026-04-30 | 4,023,864 | +6.7% | 1,215,571 | 3.31 |
| 2026-04-15 | 3,771,349 | -22.5% | 1,387,803 | 2.72 |
| 2026-03-31 | 4,867,085 | +47.2% | 1,179,353 | 4.13 |
| 2026-03-13 | 3,306,015 | +10.6% | 1,313,284 | 2.52 |
| 2026-02-27 | 2,990,382 | -8.8% | 1,048,312 | 2.85 |
| 2026-02-13 | 3,278,179 | -3.7% | 1,263,251 | 2.60 |
| 2026-01-30 | 3,403,232 | -1.5% | 986,032 | 3.45 |
| 2026-01-15 | 3,456,165 | -27.2% | 1,229,522 | 2.81 |
| 2025-12-31 | 4,747,257 | +39.8% | 1,024,896 | 4.63 |
| 2025-12-15 | 3,395,341 | -15.5% | 1,212,569 | 2.80 |
| 2025-11-28 | 4,019,572 | +7.0% | 1,951,323 | 2.06 |
| 2025-11-14 | 3,756,691 | -3.9% | 1,612,969 | 2.33 |
| 2025-10-31 | 3,907,627 | +1.1% | 1,155,317 | 3.38 |
| 2025-10-15 | 3,863,996 | -29.1% | 1,111,485 | 3.48 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 9 October 2026, the short share of NTRA volume is 48.5%, up 13.7 points over the last five sessions. Over the last 30 readings it ranged from 31.4% (5 October 2026) to 76.0% (15 September 2026). The latest reading is in line with the 30-session average of 49.3%, on 561K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-09 | 272K | 561K | 48.5% | 1 |
| 2026-10-08 | 369K | 887K | 41.5% | 523 |
| 2026-10-07 | 430K | 1.1M | 37.8% | 3,377 |
| 2026-10-06 | 582K | 1.3M | 44.8% | 883 |
| 2026-10-05 | 297K | 947K | 31.4% | 4,700 |
| 2026-10-02 | 301K | 864K | 34.9% | 1,509 |
| 2026-10-01 | 418K | 915K | 45.7% | 2,906 |
| 2026-09-30 | 451K | 909K | 49.6% | 172 |
| 2026-09-29 | 434K | 859K | 50.5% | 350 |
| 2026-09-28 | 545K | 968K | 56.3% | 2,544 |
| 2026-09-25 | 432K | 908K | 47.6% | 198 |
| 2026-09-24 | 358K | 976K | 36.6% | 283 |
| 2026-09-23 | 360K | 893K | 40.3% | 10 |
| 2026-09-22 | 427K | 796K | 53.7% | 118 |
| 2026-09-21 | 352K | 713K | 49.4% | 224 |
| 2026-09-18 | 297K | 702K | 42.3% | 5,230 |
| 2026-09-17 | 348K | 650K | 53.5% | 213 |
| 2026-09-16 | 316K | 551K | 57.4% | 468 |
| 2026-09-15 | 727K | 957K | 76.0% | 1,722 |
| 2026-09-14 | 211K | 413K | 51.1% | 508 |
| 2026-09-11 | 205K | 412K | 49.8% | 343 |
| 2026-09-10 | 230K | 452K | 51.0% | 55 |
| 2026-09-09 | 185K | 323K | 57.5% | 181 |
| 2026-09-08 | 296K | 473K | 62.7% | 10 |
| 2026-09-04 | 260K | 426K | 60.9% | 0 |
| 2026-09-03 | 169K | 341K | 49.6% | 301 |
| 2026-09-02 | 320K | 618K | 51.7% | 1,902 |
| 2026-09-01 | 261K | 514K | 50.8% | 154 |
| 2026-08-31 | 188K | 390K | 48.2% | 1,555 |
| 2026-08-28 | 195K | 408K | 47.8% | 8,546 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 8 September 2026, the fails-to-deliver balance in NTRA is 2 shares, down 26,970 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (9 July 2026) to 26,972 shares (24 August 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-08 | 2 | $328.18 | $656 |
| 2026-08-24 | 26,972 | $332.03 | $9.0M |
| 2026-08-10 | 6,433 | $322.10 | $2.1M |
| 2026-08-04 | 3,216 | $270.36 | $869K |
| 2026-07-30 | 1 | $253.82 | $254 |
| 2026-07-23 | 774 | $264.22 | $205K |
| 2026-07-21 | 1 | $262.63 | $263 |
| 2026-07-20 | 10,224 | $271.39 | $2.8M |
| 2026-07-17 | 173 | $269.83 | $47K |
| 2026-07-15 | 292 | $272.66 | $80K |
| 2026-07-09 | 1 | $274.39 | $274 |
| 2026-07-07 | 33 | $283.80 | $9K |
| 2026-07-01 | 104 | $271.45 | $28K |
| 2026-06-30 | 121 | $272.31 | $33K |
| 2026-06-25 | 1,370 | $259.97 | $356K |
| 2026-06-22 | 500 | $231.41 | $116K |
| 2026-06-18 | 22 | $226.44 | $5K |
| 2026-06-15 | 3,539 | $212.07 | $751K |
| 2026-06-12 | 15,326 | $219.23 | $3.4M |
| 2026-06-10 | 949 | $222.82 | $211K |
| 2026-06-09 | 104 | $213.47 | $22K |
| 2026-06-04 | 5,154 | $211.85 | $1.1M |
| 2026-06-03 | 5 | $212.73 | $1K |
| 2026-06-02 | 2 | $218.81 | $438 |
| 2026-05-29 | 12,831 | $213.94 | $2.7M |
| 2026-04-24 | 571 | $201.14 | $115K |
| 2026-04-21 | 516 | $207.74 | $107K |
| 2026-04-17 | 967 | $196.11 | $190K |
| 2026-04-15 | 622 | $214.64 | $134K |
| 2026-04-08 | 188 | $209.27 | $39K |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONInsiders at NTRA reported 121 open-market sells worth $84.8M in the last 90 days and no open-market buys. Latest filing: Rabinowitz Matthew (EXECUTIVE CHAIRMAN) on 2026-10-07.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-07 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Gift | 6K | $0.00 | $0 | 2.1M |
| 2026-10-01 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 2K | $415.07 | $766K | 107K |
| 2026-10-01 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 954 | $413.11 | $394K | 109K |
| 2026-10-01 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 200 | $411.62 | $82K | 110K |
| 2026-10-01 | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 1K | $413.31 | $526K | 97K |
| 2026-09-23 | Sheena Jonathan | Director, CO-FOUNDER | Sell | 220 | $390.52 | $86K | 9K |
| 2026-09-23 | Sheena Jonathan | Director, CO-FOUNDER | Sell | 2K | $389.71 | $754K | 9K |
| 2026-09-23 | Sheena Jonathan | Director, CO-FOUNDER | Sell | 1K | $388.76 | $521K | 11K |
| 2026-09-23 | Sheena Jonathan | Director, CO-FOUNDER | Sell | 3K | $387.74 | $1.1M | 12K |
| 2026-09-23 | Sheena Jonathan | Director, CO-FOUNDER | Sell | 2K | $386.64 | $889K | 15K |
| 2026-09-23 | Sheena Jonathan | Director, CO-FOUNDER | Sell | 390 | $385.29 | $150K | 18K |
| 2026-09-23 | Sheena Jonathan | Director, CO-FOUNDER | Sell | 110 | $390.42 | $43K | 9K |
| 2026-09-23 | Sheena Jonathan | Director, CO-FOUNDER | Sell | 2K | $389.69 | $904K | 9K |
| 2026-09-23 | Sheena Jonathan | Director, CO-FOUNDER | Sell | 1K | $388.71 | $503K | 11K |
| 2026-09-23 | Sheena Jonathan | Director, CO-FOUNDER | Sell | 3K | $387.65 | $1.1M | 13K |
| 2026-09-23 | Sheena Jonathan | Director, CO-FOUNDER | Sell | 2K | $386.71 | $841K | 15K |
| 2026-09-23 | Sheena Jonathan | Director, CO-FOUNDER | Sell | 400 | $385.10 | $154K | 18K |
| 2026-09-16 | Sheena Jonathan | Director, CO-FOUNDER | Sell | 200 | $356.87 | $71K | 221K |
| 2026-09-16 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Gift | 945 | $0.00 | $0 | 110K |
| 2026-09-16 | Sheena Jonathan | Director, CO-FOUNDER | Sell | 800 | $355.95 | $285K | 222K |
| 2026-09-16 | Sheena Jonathan | Director, CO-FOUNDER | Sell | 450 | $354.91 | $160K | 222K |
| 2026-09-16 | Sheena Jonathan | Director, CO-FOUNDER | Sell | 1K | $353.83 | $495K | 223K |
| 2026-09-16 | Sheena Jonathan | Director, CO-FOUNDER | Sell | 100 | $349.05 | $35K | 224K |
| 2026-09-16 | Sheena Jonathan | Director, CO-FOUNDER | Sell | 200 | $348.02 | $70K | 224K |
| 2026-09-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 3K | $347.81 | $939K | 2.2M |
| 2026-09-15 | Sheena Jonathan | Director, CO-FOUNDER | Sell | 6K | $350.07 | $2.1M | 224K |
| 2026-09-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 2K | $350.01 | $700K | 0 |
| 2026-09-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 800 | $351.25 | $281K | 2.1M |
| 2026-09-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 15K | $350.81 | $5.1M | 2.1M |
| 2026-09-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 4K | $349.51 | $1.5M | 2.1M |
| 2026-09-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 8K | $348.65 | $2.8M | 2.1M |
| 2026-09-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 1K | $346.68 | $389K | 2.2M |
| 2026-09-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 3K | $345.38 | $933K | 2.2M |
| 2026-09-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 6K | $344.49 | $2.0M | 2.2M |
| 2026-09-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 2K | $343.56 | $770K | 2.2M |
| 2026-09-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 2K | $342.18 | $669K | 2.2M |
| 2026-09-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 2K | $341.41 | $619K | 2.2M |
| 2026-09-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 3K | $340.25 | $867K | 2.2M |
| 2026-09-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 1K | $339.24 | $502K | 2.2M |
| 2026-09-14 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 4K | $342.51 | $1.4M | 2.2M |
| 2026-09-14 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 3K | $341.35 | $922K | 2.2M |
| 2026-09-14 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 2K | $340.31 | $681K | 2.2M |
| 2026-09-14 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 2K | $339.37 | $713K | 2.2M |
| 2026-09-14 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 1K | $338.30 | $474K | 2.2M |
| 2026-09-14 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 2K | $337.17 | $744K | 2.2M |
| 2026-09-14 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 8K | $336.27 | $2.8M | 2.2M |
| 2026-09-14 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 4K | $335.18 | $1.3M | 2.2M |
| 2026-09-14 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 3K | $334.24 | $942K | 2.2M |
| 2026-09-14 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 2K | $333.07 | $748K | 2.2M |
| 2026-09-14 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 1K | $332.02 | $332K | 2.2M |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON50 Form 144 notices on file for NTRA worth $255.3M at the prices reported; 16 in the last 90 days worth $86.6M. Latest: SOLOMON MOSHKEVICH filed on 2026-10-01 to sell 3,000 shares ($1.2M) from 2026-10-01.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-10-01 | SOLOMON MOSHKEVICHOfficer | 3K | $1.2M | 0.002% | 2026-10-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-10-01 | STEVEN L CHAPMANOfficer, Director | 1K | $526K | 0.001% | 2026-10-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-23 | Sheena JonathanDirector | 21K | $8.2M | 0.015% | 2026-09-23 | Charles Schwab & Co., Inc. |
| 2026-09-15 | TINKERBELLE II TR U/A DTD 10/22/2021Officer, Director | 2K | $700K | 0.001% | 2026-09-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-11 | MATTHEW RABINOWITZDirector, Officer | 200K | $65.2M | 0.139% | 2026-09-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-01 | SOLOMON MOSHKEVICHOfficer | 3K | $962K | 0.002% | 2026-09-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-01 | STEVEN L CHAPMANOfficer, Director | 2K | $545K | 0.001% | 2026-09-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-07 | TINKERBELLE II TR U/A DTD 10/22/2021Officer, Director | 2K | $642K | 0.001% | 2026-08-07 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-07 | Sheena JonathanDirector | 18K | $6.0M | 0.012% | 2026-08-07 | Charles Schwab & Co., Inc. |
| 2026-08-04 | MICHAEL BROPHYOfficer | 478 | $129K | 0.000% | 2026-08-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-03 | SOLOMON MOSHKEVICHOfficer | 3K | $796K | 0.002% | 2026-08-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-03 | STEVEN L CHAPMANOfficer, Director | 2K | $503K | 0.001% | 2026-08-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-29 | MICHAEL BROPHYOfficer | 2K | $470K | 0.001% | 2026-07-29 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-28 | MICHAEL BROPHYOfficer | 1K | $304K | 0.001% | 2026-07-28 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-15 | Sheena JonathanDirector | 2K | $413K | 0.001% | 2026-07-15 | Charles Schwab & Co., Inc. |
| 2026-07-15 | ROWAN EMMA CHAPMANDirector | 135 | $37K | 0.000% | 2026-07-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-13 | Sheena JonathanDirector | 9K | $2.5M | 0.007% | 2026-07-13 | Charles Schwab & Co., Inc. |
| 2026-07-06 | TINKERBELLE II TR U/A DTD 10/22/2021Officer, Director | 1K | $280K | 0.001% | 2026-07-06 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-01 | DANIEL RABINOWITZOfficer | 17K | $4.6M | 0.012% | 2026-07-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-01 | SOLOMON MOSHKEVICHOfficer | 3K | $819K | 0.002% | 2026-07-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-24 | DANIEL RABINOWITZOfficer | 34K | $7.9M | 0.023% | 2026-06-24 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-24 | HERMAN ROSENMANDirector | 17K | $4.1M | 0.012% | 2026-06-24 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-16 | ROWAN EMMA CHAPMANDirector | 3K | $643K | 0.002% | 2026-06-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-12 | MATTHEW RABINOWITZDirector, Officer | 100K | $21.9M | 0.070% | 2026-06-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-05 | GAIL MARCUSDirector | 11K | $2.4M | 0.008% | 2026-06-05 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-04 | STEVEN L CHAPMANOfficer, Director | 41K | $9.1M | 0.029% | 2026-06-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-01 | SOLOMON MOSHKEVICHOfficer | 3K | $655K | 0.002% | 2026-06-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-01 | BV369 TRUSTAffiliate | 78K | $17.2M | 0.054% | 2026-06-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-04 | MICHAEL BROPHYOfficer | 482 | $100K | 0.000% | 2026-05-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-01 | SOLOMON MOSHKEVICHOfficer | 3K | $610K | 0.002% | 2026-05-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-29 | MICHAEL BROPHYOfficer | 3K | $615K | 0.002% | 2026-04-29 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-01 | SOLOMON MOSHKEVICHOfficer | 3K | $607K | 0.002% | 2026-04-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-20 | Sheena JonathanDirector | 6K | $1.2M | 0.004% | 2026-03-20 | Charles Schwab & Co., Inc. |
| 2026-03-18 | Sheena JonathanDirector | 12K | $2.5M | 0.009% | 2026-03-18 | Charles Schwab & Co., Inc. |
| 2026-03-13 | ROWAN EMMA CHAPMANDirector | 122 | $23K | 0.000% | 2026-03-13 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-12 | MATTHEW RABINOWITZDirector, Officer | 200K | $39.3M | 0.141% | 2026-03-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-06 | DANIEL RABINOWITZOfficer | 17K | $3.3M | 0.012% | 2026-03-06 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-02 | SOLOMON MOSHKEVICHOfficer | 3K | $600K | 0.002% | 2026-03-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-02 | STEVEN L CHAPMANOfficer, Director | 4K | $790K | 0.003% | 2026-03-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-03 | MICHAEL BROPHYOfficer | 6K | $1.3M | 0.004% | 2026-02-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-02 | SOLOMON MOSHKEVICHOfficer | 3K | $694K | 0.002% | 2026-02-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-02 | STEVEN L CHAPMANOfficer, Director | 85K | $19.7M | 0.062% | 2026-02-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-29 | MICHAEL BROPHYOfficer | 2K | $440K | 0.001% | 2026-01-29 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-28 | MICHAEL BROPHYOfficer | 1K | $283K | 0.001% | 2026-01-28 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-21 | MICHAEL BROPHYOfficer | 37K | $8.6M | 0.026% | 2026-01-21 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-02 | SOLOMON MOSHKEVICHOfficer | 3K | $676K | 0.002% | 2026-01-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-02 | STEVEN L CHAPMANOfficer, Director | 4K | $881K | 0.003% | 2026-01-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-19 | Sheena JonathanDirector | 5K | $990K | 0.003% | 2025-12-19 | Charles Schwab & Co., Inc. |
| 2025-12-17 | Sheena JonathanDirector | 9K | $2.1M | 0.007% | 2025-12-17 | Charles Schwab & Co., Inc. |
| 2025-12-12 | Herm Rosenman TrustBoard member | 48K | $11.3M | 0.035% | 2025-12-12 | UBS Financial Services Inc |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON3 holders report 5% or more of NTRA in their latest filing, all on Schedule 13G (passive). The largest reported stake is JPMORGAN CHASE & CO. at 9.1% of the class (12,825,640 shares), filed 2026-01-23 for an event on 2025-12-31.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-14 | 13G/Ano. 4 | T. Rowe Price Associates, Inc.investment adviser | 9.0M | 6.3% | 2026-06-30 |
| 2026-04-30 | 13G | Vanguard Capital Managementinvestment adviser | 7.2M | 5.1% | 2026-03-31 |
| 2026-03-27 | 13G/Ano. 7 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2026-01-23 | 13G/Ano. 2 | JPMORGAN CHASE & CO.parent holding company | 12.8M | 9.1% | 2025-12-31 |
13F holders
Tracked managers holding NTRA at their latest 13F. JSON11 of the 30 tracked managers held NTRA at their latest 13F, $3.00B in total at quarter-end prices. Duquesne Family Office is the largest at $864.9M (16.6% of its portfolio) as of 2026-06-30. Over the prior quarter 6 added shares and 5 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Duquesne Family Office | 2026-06-30 | 3.2M | $864.9M | 16.60% | +123K |
| Coatue Management | 2026-06-30 | 2.5M | $680.0M | 1.40% | -37K |
| AQR Capital Management | 2026-06-30 | 2.3M | $628.1M | 0.22% | +71K |
| D. E. Shaw & Co. | 2026-06-30 | 1.3M | $347.3M | 0.17% | +788K |
| ARK Investment Management | 2026-06-30 | 689K | $187.0M | 1.21% | +5K |
| Viking Global Investors | 2026-06-30 | 391K | $106.1M | 0.30% | new |
| Citadel Advisors | 2026-06-30 | 266K | $72.1M | 0.01% | +154K |
| Point72 Asset Management | 2026-06-30 | 253K | $68.7M | 0.08% | -191K |
| Millennium Management | 2026-06-30 | 144K | $39.1M | 0.01% | -12K |
| Two Sigma Investments | 2026-06-30 | 33K | $8.8M | 0.01% | -8K |
| Bridgewater Associates | 2026-06-30 | 6K | $1.7M | 0.01% | -19K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) Natera reported revenue of $752.8M, up 37.7% from the same quarter a year earlier, and net loss of $67.0M (-0.47 diluted EPS). In FY 2025 it generated $215.3M of operating cash flow.
- Equity
- $1.82B
- Total assets
- $2.66B
- Shares outstanding
- 144,144,170
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $752.8M | -$67.0M | -8.9% | -0.47 |
| Q1 FY 2026 | 2026-03-31 | $696.6M | -$85.1M | -12.2% | -0.60 |
| Q4 FY 2025derived | 2025-12-31 | $665.5M | $47.3M | 7.1% | n/a |
| Q3 FY 2025 | 2025-09-30 | $592.2M | -$87.5M | -14.8% | -0.64 |
| Q2 FY 2025 | 2025-06-30 | $546.6M | -$100.9M | -18.5% | -0.74 |
| Q1 FY 2025 | 2025-03-31 | $501.8M | -$66.9M | -13.3% | -0.50 |
| Q4 FY 2024derived | 2024-12-31 | $476.1M | -$53.8M | -11.3% | n/a |
| Q3 FY 2024 | 2024-09-30 | $439.8M | -$31.6M | -7.2% | -0.26 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $2.31B | -$208.2M | $215.3M | $106.2M | n/a | n/a |
| FY 2024 | 2024-12-31 | $1.70B | -$190.4M | $135.7M | $66.4M | n/a | n/a |
| FY 2023 | 2023-12-31 | $1.08B | -$434.8M | -$247.0M | $39.2M | n/a | n/a |
| FY 2022 | 2022-12-31 | $820.2M | -$547.8M | -$431.5M | $47.7M | n/a | n/a |
| FY 2021 | 2021-12-31 | $625.5M | -$471.7M | -$335.2M | $41.0M | n/a | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-31 from the cover page.
What this page is
Natera in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Natera (NTRA), SEC CIK 1604821, listed on Nasdaq, classified by the SEC as services-medical laboratories. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-09.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-08.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-10-01.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-14.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-06.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-07.JSON and CSV
- Company record
- EDGAR filing index for CIK 1604821Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as services-medical laboratories
Other company pages
Datasets
Frequently Asked Questions
How much of NTRA is sold short?
6,355,450 shares were held short at the 2026-09-30 settlement, 3.2 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is NTRA's daily short volume?
On 2026-10-09, 272,424 of the 561,375 NTRA shares reported to FINRA were sold short, 48.5% of the day's reported volume. Short volume is a flow for one day, not a position.
Does NTRA have fails to deliver?
The SEC's latest file shows 2 NTRA shares failed to deliver at settlement 2026-09-08. Fails are reported per settlement date and published twice a month with a lag.
Are NTRA insiders buying or selling?
Insiders at NTRA reported 121 open-market sells worth $84.8M in the last 90 days and no open-market buys. Latest filing: Rabinowitz Matthew (EXECUTIVE CHAIRMAN) on 2026-10-07.
Have NTRA insiders filed to sell?
50 Form 144 notices on file for NTRA worth $255.3M at the prices reported; 16 in the last 90 days worth $86.6M. Latest: SOLOMON MOSHKEVICH filed on 2026-10-01 to sell 3,000 shares ($1.2M) from 2026-10-01.
Who owns 5% or more of NTRA?
3 holders report 5% or more of NTRA in their latest filing, all on Schedule 13G (passive). The largest reported stake is JPMORGAN CHASE & CO. at 9.1% of the class (12,825,640 shares), filed 2026-01-23 for an event on 2025-12-31.
What did NTRA report last quarter?
In Q2 FY 2026 (quarter ended 2026-06-30) Natera reported revenue of $752.8M, up 37.7% from the same quarter a year earlier, and net loss of $67.0M (-0.47 diluted EPS). In FY 2025 it generated $215.3M of operating cash flow.
Which tracked 13F managers own NTRA?
11 of the 30 tracked 13F managers held NTRA shares at their latest filing, $3.00B in all. The largest: Stanley Druckenmiller's Duquesne Family Office (3.2M shares, $864.9M), Philippe Laffont's Coatue Management (2.5M shares, $680.0M), Cliff Asness's AQR Capital Management (2.3M shares, $628.1M), D. E. Shaw & Co. (1.3M shares, $347.3M), Cathie Wood's ARK Investment Management (689K shares, $187.0M), Andreas Halvorsen's Viking Global Investors (391K shares, $106.1M). The table above lists all 11.
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.